NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NLM E-111-2016-7-DE-01 Novel CRISPR Enzymes And Systems DE EP 16742455.5 Issued
NLM E-111-2016-7-FI-01 Novel CRISPR Enzymes And Systems FI EP 16742455.5 Issued
NLM E-111-2016-7-FR-01 Novel CRISPR Enzymes And Systems FR EP 16742455.5 Issued
NLM E-111-2016-7-BE-01 Novel CRISPR Enzymes And Systems BE EP 16742455.5 Issued
NLM E-111-2016-7-NO-01 Novel CRISPR Enzymes And Systems NO EP 16742455.5 Issued
NLM E-111-2016-7-SE-01 Novel CRISPR Enzymes And Systems SE EP 16742455.5 Issued
NLM E-110-2016-2-EP-04 Novel CRISPR Enzymes And Systems EP National Stage 16738253.0 Pending
NIAID E-064-2016-1-IN-06 SUBSTITUTIONS-MODIFIED PREFUSION RSV F PROTEINS
AND THEIR USE 		IN National Stage 201817030203 Pending
NIAID E-064-2016-1-AU-02 RSV F IMMUNOGENS AND THEIR USE AU National Stage 2017242020 Issued
NCI E-051-2016-0-US-03 METHOD OF SENSITIZING CANCER CELLS TO THE CYTOTOXIC EFFECTS OF APOPTOSIS INDUCING LIGANDS IN CANCER TREATMENT US National Stage 16/076,954 10849912 Issued PDF
NCI E-078-2016-0-US-03 RNA/DNA HYBRID NANOPARTICLES MODIFIED WITH SINGLE STRANDED RNA TOEHOLDS AND USES THEREOF US National Stage 16/076,878 Abandoned
NIEHS E-210-2017-0-CN-03 COMPOSITIONS AND METHODS FOR INHIBITING HIV-1
REVERSE TRANSCRIPTASE 		CN National Stage 2018800636827 Abandoned
NIEHS E-210-2017-0-PCT-02 Novel Strategy For Inhibiting HIV-1 Reverse Transcriptase PCT PCT PCT/US2018/045874 Expired
NIEHS E-210-2017-0-IL-05 Novel Strategy For Inhibiting HIV-1 Reverse Transcriptase IL National Stage 272409 Abandoned
NIEHS E-210-2017-0-EP-04 COMPOSITIONS AND METHODS FOR INHIBITING HIV-1
REVERSE TRANSCRIPTASE 		EP National Stage 18766424.8 Abandoned
NCI E-101-2016-0-US-05 GENE SIGNATURE PREDICTIVE OF HEPATOCELLULAR CARCINOMA RESPONSE TO TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION (TACE) US National Stage 16/076,239 11306362 Issued PDF
NCI E-078-2012-0-EP-07 Anti-Mesothelin Chimeric Antigen Receptors EP DIV 18187755.6 Issued
NCI E-078-2012-0-FR-12 Anti-Mesothelin Chimeric Antigen Receptors FR EP 18187755.6 Issued
NCI E-078-2012-0-DE-13 Anti-Mesothelin Chimeric Antigen Receptors DE EP 18187755.6 Issued
NCI E-078-2012-0-GB-14 Anti-Mesothelin Chimeric Antigen Receptors GB EP 18187755.6 Issued
NIAID E-037-2016-0-JP-07 RECOMBINANT RESPIRATORY SYNCYTIAL VIRUS (RSV) STRAINS COMPRISING NS1 AND NS2 GENE SHIFTS JP National Stage 2018-530502 Issued
NIBIB E-005-2012-2-US-07 MULTI-FOCAL STRUCTURED ILLUMINATION MICROSCOPY SYSTEMS AND METHODS US CON 16/053,533 10281702 Issued PDF
NIAID E-005-2017-0-PCT-02 HEPATITIS B NANOPARTICLE-BASED VACCINE FOR INFLUENZA VIRUS PCT PCT PCT/US2018/045032 Expired
NIAID E-005-2017-0-CN-03 HEPATITIS B NANOPARTICLE-BASED VACCINE FOR INFLUENZA VIRUS CN National Stage 201880063622.5 Pending
NIAID E-005-2017-0-EP-04 HEPATITIS B NANOPARTICLE-BASED VACCINE FOR INFLUENZA VIRUS EP National Stage 18756111.3 Pending
NIAID E-005-2017-0-IN-05 HEPATITIS B NANOPARTICLE-BASED VACCINE FOR INFLUENZA VIRUS IN National Stage 202017008138 Pending
NIAID E-257-2015-0-US-03 COMPOUNDS FOR MODULATING FC-EPSILON-RI-BETA EXPRESSION AND USES THEREOF US CON 16/052,130 Pending
NCI E-230-2011-1-US-20 VASCULAR ENDOTHELIAL GROWTH FACTOR ANTAGONISTS US CON 16/051,062 11434268 Issued PDF
NICHD E-552-2013-0-GB-27 ADENO-ASSOCIATED VIRUS VECTORS FOR TREATMENT OF GLYCOGEN STORAGE DISEASE GB EP 18186594.0 Issued
NICHD E-552-2013-0-DE-25 ADENO-ASSOCIATED VIRUS VECTORS FOR TREATMENT OF GLYCOGEN STORAGE DISEASE DE EP 18186594.0 Issued
NICHD E-552-2013-0-FR-26 ADENO-ASSOCIATED VIRUS VECTORS FOR TREATMENT OF GLYCOGEN STORAGE DISEASE FR EP 18186594.0 Issued
NICHD E-552-2013-0-EP-14 ADENO-ASSOCIATED VIRUS VECTORS FOR TREATMENT OF GLYCOGEN STORAGE DISEASE EP DIV 18186594.0 Issued
NHLBI E-124-2014-3-US-04 Device For Closure Of Transvascular Or Transcameral Access Ports US CON 16/049,946 Pending
NCI E-035-2021-0-HU-01 A Method For The Early Detection Of Breast Cancer HU ORD P1800271 Pending
NCI E-193-2017-0-PCT-02 Ultrasound Sensitive Peptide Nanoparticles For Spatially Resolved Molecule Delivery PCT PCT PCT/US2018/044382 Expired
NHLBI E-758-2013-1-US-05 ANTIBODY TARGETING CELL SURFACE DEPOSITED COMPLEMENT PROTEIN C3d AND USE THEREOF US DIV 16/047,929 11384139 Issued PDF
NCI E-105-2012-0-JP-13 Murine Anti-NY-ESO-1 T Cell Receptors JP DIV 2018-139890 Abandoned
NCI E-181-2018-0-CN-01 Discovery, Synthesis And Evaluation Of Oxynitidine Derivatives As Dual Inhibitors Of DNA Topoisomerase IB (TOP1) And Tyrosyl-DNA Phosphodiesterase 1 (TDP1), And Potential Antitumor Agents CN ORD 201810827467.1 Pending
NLM E-111-2016-7-CA-03 Novel CRISPR Enzymes And Systems CA National Stage 3012631 Pending
NIAID E-051-2012-3-US-11 BROADLY NEUTRALIZING HIV-1 ANTIBODIES THAT BIND TO THE CD4-BINDING SITE OF THE ENVELOPE PROTEIN US DIV 16/044,083 10815295 Issued PDF
NCATS E-004-2016-0-CN-05 SMALL MOLECULE BET BROMODOMAIN INHIBITORS AND USES THEREOF CN National Stage 201680079771.1 Issued
NIAID E-099-2016-1-US-01 JSE OF GRAM NEGATIVE SPECIES TO TREAT ATOPIC DERMATITIS US CIP 16/042,939 10293005 Abandoned PDF
NCI E-148-2011-0-JP-16 Anti-Epidermal Growth Factor Receptor Variant III Chimeric Antigen Receptors And Use Of Same For The Treatment Of Cancer JP DIV 2018-137193 Issued
NCI E-010-2008-0-US-05 METHODS AND COMPOSITIONS FOR PROTEIN DELIVERY US CON 16/041,395 10577397 Issued PDF
NCI E-205-2010-2-JP-12 Photosensitizing Antibody-Flurophore Conjugates JP DIV 2018-136580 Pending
NIAMS E-192-2017-0-HK-07 ANTIBODIES AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF HEPATITIS B VIRUS INFECTION HK EP 62020019675.1 Issued
NIAMS E-192-2017-0-PCT-02 ANTIBODIES AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF HEPATITIS B VIRUS INFECTION PCT PCT PCT/US2018/042870 Expired
NCI E-089-2016-0-EP-03 Niclosamide Therapy For Adrenal Cancer EP National Stage 17702246.4 Abandoned
NINDS E-143-2002-1-HK-76 Method For the Treatment of Multiple Sclerosis HK EP 18109281.9 Abandoned
NCI E-040-2012-0-ID-28 Chimeric Antigen Receptors Targeting B-cell Maturation Antigen ID DIV P-00201805294 Pending